Increased risk of wheeze and decreased lung function after respiratory syncytial virus infection

PLoS One. 2014 Jan 31;9(1):e87162. doi: 10.1371/journal.pone.0087162. eCollection 2014.

Abstract

Background: A relationship between hospitalization for respiratory syncytial virus (RSV) bronchiolitis and asthma development has been suggested in case-control studies.

Objective: The aim of this study was to assess the risk of current wheeze, asthma, and lung function at school age in infants previously hospitalized for RSV bronchiolitis compared to non-hospitalized children.

Methods: For this study, data from a prospective birth cohort of unselected, term-born infants (n = 553), of whom 4 (0.7%) were hospitalized for RSV bronchiolitis, and a prospective patient cohort of 155 term infants hospitalized for RSV bronchiolitis were used. Respiratory outcomes at age 6 in children hospitalized for RSV bronchiolitis were compared to non-hospitalized children.

Results: The risk of current wheeze was higher in hospitalized patients (n = 159) compared to non-hospitalized children (n = 549) (adjusted odds ratio (OR) 3.2 (95% CI 1.2-8.1). Similarly, the risk of current asthma, defined as a doctor's diagnosis of asthma plus current symptoms or medication use, was higher in hospitalized patients (adjusted OR 3.1 (95% CI 1.3-7.5). Compared to non-hospitalized children, RSV bronchiolitis hospitalization was associated with lower lung function (mean difference FEV1% predicted -6.8 l (95% CI (-10.2 to -3.4).

Conclusions and clinical relevance: This is the first study showing that hospitalization for RSV bronchiolitis during infancy is associated with increased risk of wheezing, current asthma, and impaired lung function as compared to an unselected birth cohort at age 6.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Asthma / etiology
  • Asthma / physiopathology*
  • Bronchiolitis, Viral / etiology
  • Bronchiolitis, Viral / physiopathology*
  • Case-Control Studies
  • Child
  • Child, Preschool
  • Female
  • Follow-Up Studies
  • Hospitalization / statistics & numerical data
  • Host-Pathogen Interactions
  • Humans
  • Logistic Models
  • Lung / physiopathology
  • Lung / virology
  • Male
  • Prospective Studies
  • Respiratory Function Tests
  • Respiratory Sounds / etiology
  • Respiratory Sounds / physiopathology*
  • Respiratory Syncytial Virus Infections / complications
  • Respiratory Syncytial Virus Infections / physiopathology*
  • Respiratory Syncytial Virus Infections / virology
  • Respiratory Syncytial Virus, Human / physiology
  • Risk Factors

Grants and funding

LB received a grant for this study from Teva Pharmaceutical industries inc., and from the Dutch Asthma Foundation. MR received an educational grant from Abbott, to provide financial support without restrictions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.